# Characterizing the Association Between Asthma and Clinical Outcomes in Emergency Department Patients With Symptomatic COVID-19

## TL;DR

This study found no significant link between asthma and severe outcomes like intubation or death in ED patients with symptomatic COVID-19.

## Contribution

The study provides new evidence on asthma's role in ED patients with symptomatic COVID-19 outcomes.

## Key findings

- Asthma was not significantly associated with intubation or death (RR: 0.97; 95% CI: 0.86-1.1).
- Patients aged 80+ had the highest risk for intubation or death (RR: 10.54; 95% CI: 7.01-15.85).
- ICS users had a slightly higher risk of the primary outcome (RR: 1.12; 95% CI: 1.01-1.25).

## Abstract

Few studies have investigated the risks of developing intubation and death in patients seen in the emergency department (ED) with COVID-19 and pre-existing asthma. We conducted a retrospective cohort study using data from the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) from March 1st, 2020, to December 31st, 2021. Inclusion criteria were age ≥18 and a positive SARS-CoV-2 test. The primary outcome was a composite of intubation or death, and the secondary outcome was severe COVID-19, as defined by the World Health Organization. Multivariable modified Poisson regression was used to assess the association between asthma and outcomes, adjusted for possible confounding. Out of 38,139 patients, 2,826 (7.41%) had asthma, and 17.1% were using inhaled corticosteroids (ICS). The study found no significant evidence suggesting an association between asthma and intubation or death in the hospital (relative risk (RR): 0.97; 95% CI: 0.86-1.1). The highest risk group for the primary outcome was patients aged 80+ years (RR: 10.54; 95% CI: 7.01-15.85), compared to the reference group 18-29 years. Users of ICS agents had a slightly higher risk of the primary outcome compared to non-ICS users (RR: 1.12; 95% CI: 1.01-1.25).